Nuveen, LLC Exact Sciences Corp Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Nuveen, LLC holds 1,047,216 shares of EXAS stock, worth $55.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,047,216Holding current value
$55.9 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
669Shares Held
151MCall Options Held
4.22MPut Options Held
1.93M-
Capital World Investors Los Angeles, CA17.8MShares$952 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$942 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$644 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$333 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$308 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.45B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...